Plasma endothelin-1 concentrations in the coronary sinus in dogs with artificially induced myocardial infarction
- PMID: 1480507
- DOI: 10.1016/0196-9781(92)90064-a
Plasma endothelin-1 concentrations in the coronary sinus in dogs with artificially induced myocardial infarction
Abstract
We have previously reported the marked increase in plasma levels of endothelin-1 in patients with acute myocardial infarction (AMI). To investigate the effects of severe myocardial ischemia on the production of endothelin-1, plasma concentrations of endothelin-1 were measured by a sandwich-type enzyme immunoassay that we developed recently in both the coronary sinus and the aorta of dogs with artificially induced AMI. Dogs were anesthetized and chests were opened. The proximal left anterior descending coronary artery was completely occluded by ligation for 1 h and then was reperfused for 1 h. Throughout the experiment (at the end of occlusion for 1 h, at the beginning of reperfusion, at the end of reperfusion for 1 h), plasma endothelin-1 levels were not significantly altered either in the coronary sinus or in the aorta. The present findings indicate that severe myocardial ischemia itself does not affect the production of endothelin-1 in the coronary circulation of dogs.
Similar articles
-
Deterioration in myocardial blood flow following relief of sustained ischemia is not associated with release of endothelin into the coronary sinus.Basic Res Cardiol. 1994 May-Jun;89(3):260-9. doi: 10.1007/BF00795618. Basic Res Cardiol. 1994. PMID: 7945162
-
Endothelin and myocardial ischemia.Cardiovasc Drugs Ther. 1994 Aug;8(4):589-99. doi: 10.1007/BF00877413. Cardiovasc Drugs Ther. 1994. PMID: 7848895 Review.
-
Plasma endothelin levels during myocardial ischemia and reperfusion.Life Sci. 1991;48(18):1745-9. doi: 10.1016/0024-3205(91)90211-s. Life Sci. 1991. PMID: 2020257
-
Changes in plasma levels of ET-1 and its precursor, big ET-1, in the arterial and venous circulation following double myocardial ischemia-reperfusion injury in dogs.J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S215-20. J Cardiovasc Pharmacol. 2000. PMID: 11078381
-
[Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].Arch Cardiol Mex. 2006 Oct-Dec;76 Suppl 4:S76-101. Arch Cardiol Mex. 2006. PMID: 17469337 Review. Spanish.
Cited by
-
Deterioration in myocardial blood flow following relief of sustained ischemia is not associated with release of endothelin into the coronary sinus.Basic Res Cardiol. 1994 May-Jun;89(3):260-9. doi: 10.1007/BF00795618. Basic Res Cardiol. 1994. PMID: 7945162
-
Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.Br J Pharmacol. 1994 Nov;113(3):869-76. doi: 10.1111/j.1476-5381.1994.tb17073.x. Br J Pharmacol. 1994. PMID: 7858879 Free PMC article.
-
Endothelin-1 mediated inhibition of the acetylcholine-activated potassium current from rabbit isolated atrial cardiomyocytes.Br J Pharmacol. 1996 Dec;119(7):1427-37. doi: 10.1111/j.1476-5381.1996.tb16055.x. Br J Pharmacol. 1996. PMID: 8968552 Free PMC article.
-
Endothelin and myocardial ischemia.Cardiovasc Drugs Ther. 1994 Aug;8(4):589-99. doi: 10.1007/BF00877413. Cardiovasc Drugs Ther. 1994. PMID: 7848895 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical